Latest news for BMW (OTC:BYMOF) Stock

In addition to being one of the world's leading premium light-vehicle manufacturers, BMW Group produces BMW motorcycles and provides financial services. Premium light-vehicle brands include BMW, Mini, and ultraluxury brand Rolls-Royce. Operations include 31 production facilities in 15 countries, research and development facilities in 17 countries, and a sales network reaching over 140 countries. In 2023, worldwide sales volume was over 2.5 million automobiles and over 209,000 motorcycles.

Cannabis

Government

News

Penny Stocks

Regulations

Politics

Legal

Success Stories

Startups

Small Business

After-Hours Center

Markets

General

BYMOF

Bright Green Corp., a Fort Lauderdale-based company with conditional approval from the DEA to produce cannabis, is filing to list its shares on the NASDAQ under the ticker symbol “BGXX”.  

DEA-Licensed Cannabis Producer Bright Green Corp Heading For NASDAQ, Current Valuation $650M

BAYERISCHE MOTORNWRKE PFD by Bayerische Motoren Werke AG

Bayerische Motoren Werke AG

BMW GAAP EPS of €17.67, revenue of €155.5B; initiates FY24 outlook

Bayerische Motoren Werke Aktiengesellschaft (BMWYY) Q4 2023 Earnings Call Transcript

EV Company News For The Month Of March 2024

Tesla Is No Longer A Growth Stock Even Though It's Valued Like One

Rolls-Royce: A Difficult Decision

Lucid: Weak Fundamentals And Unfair Valuation

EV Company News For The Month Of April 2024

Bayerische Motoren Werke Aktiengesellschaft 2024 Q1 - Results - Earnings Call Presentation

Bayerische Motoren Werke Aktiengesellschaft (BMWYY) Q1 2024 Earnings Call Transcript

ZEEKR: A New EV Superstar

AYRO

BAMXF

BATT

BCCMY

BLBD

BLNK

BMCLF

BMWYY

BYDDF

BYDDY

DNFGF

DNFGY

DRPRF

DRPRY

ELMSQ

ELMWQ

EVTV

FUJHF

FUJHY

GELYF

GELYY

GOEV

GOEVW

GWLLF

GWLLY

HNDAF

HYLN

HYMTF

IDEX

KNDI

LAAOF

LCID

MAHMF

MBGAF

MBGYY

MMTOF

MZDAF

MZDAY

NIOIF

NKLA

NSANF

NSANY

POAHF

POAHY

RACE

RIVN

RLLCF

RNLSY

RNSDF

RYCEF

RYCEY

STLA

SZKMF

SZKMY

TOYOF

TSLA

VFSWW

VLKAF

VLKPF

VWAGY

VWAPY

WKHS

XIACF

XIACY

XPEV

XPNGF

Bright Green Corp., a Fort Lauderdale-based company with conditional approval from the DEA&nbsp;to produce&nbsp;cannabis, is filing to list its shares on the NASDAQ&nbsp;under the ticker symbol &ldquo;BGXX&rdquo;. &nbsp;

One of the&nbsp;very few companies selected by the US government to grow, manufacture&nbsp;and sell,&nbsp;legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and export, Green Bright is&nbsp;led by CEO Edward A. Robinson, a former executive at BMW (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYMOF#OTC">BYMOF</a>)&nbsp;Financial Services, and chairman Terry Rafih, owner and CEO of Rafih Automotive Group.

Bright Green&nbsp;disclosed 157.6 million shares of stock held privately by 425 stockholders of record as of Feb. 28. Based on a price of $4 a share in a private stock sale in January, the company&rsquo;s current valuation is about $630 million, which would make it larger than many U.S. cannabis companies that trade on the Canadian Securities Exchange and the OTC market, noted Market Watch.

Bright Green Corp. is working with EF Hutton, a division of Benchmark Investments LLC, to list its shares and to propose a public market price when the stock debuts.

In&nbsp;May&nbsp;2021, the company&nbsp;entered into a&nbsp;memorandum of agreement with the DEA to grow cannabis for federally sanctioned research. Bright Green Corp. expects to win final registration in May, contingent upon completion of construction and a successful inspection by the DEA of its grow facilities.&nbsp;

&ldquo;We plan to sell cannabis to research institutions pursuant to our conditional approval from the DEA,&rdquo; the company reported. &ldquo;Sales of THC cannabis products will be made only via bona fide supply agreements from existing DEA registrants, and not directly to consumers.&rdquo;

Bright Green said it plans to receive a Controlled Substances Bulk Manufacturing License from the DEA, although there is no guarantee it will win final approval.

&ldquo;Given the competitiveness of the process to obtain a DEA registration to cultivate and process cannabis, and the continued federal illegality of cannabis in the U.S., we believe we will be uniquely positioned to capture significant parts of the cannabis research supply market,&rdquo; the company noted.

&ldquo;We will operate legally under all applicable laws and be authorized by the federal government to sell cannabis commercially for research and manufacturing purposes, export cannabis for international cannabis research purposes, and sell cannabis to DEA-registered pharmaceutical companies for the production of medical cannabis products and preparations,&rdquo; Bright Green&nbsp;wrote in its prospectus.

Photo by&nbsp;<a href="https://unsplash.com/@meric?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Meri&ccedil; Dağlı</a>&nbsp;on&nbsp;<a href="https://unsplash.com/s/photos/nasdaq?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

&nbsp;

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Comments

BMW

News

Latest news for BMW (OTC:BYMOF) Stock

Tuesday, March 29, 2022